Navigation Links
UT Arlington physics team demonstrates new power generation technique

A University of Texas at Arlington physics professor has helped create a hybrid nanomaterial that can be used to convert light and thermal energy into electrical current, surpassing earlier methods that used either light or thermal energy, but not both.

Working with Louisiana Tech University assistant professor Long Que, UT Arlington associate physics professor Wei Chen and graduate students Santana Bala Lakshmanan and Chang Yang synthesized a combination of copper sulfide nanoparticles and single-walled carbon nanotubes.

The team used the nanomaterial to build a prototype thermoelectric generator that they hope can eventually produce milliwatts of power. Paired with microchips, the technology could be used in devices such as self-powering sensors, low-power electronic devices and implantable biomedical micro-devices, Chen said.

"If we can convert both light and heat to electricity, the potential is huge for energy production," Chen said. "By increasing the number of the micro-devices on a chip, this technology might offer a new and efficient platform to complement or even replace current solar cell technology."

In lab tests, the new thin-film structure showed increases by as much at 80 percent in light absorption when compared to single-walled nanotube thin-film devices alone, making it a more efficient generator.

Copper sulfide is also less expensive and more environment-friendly than the noble metals used in similar hybrids.

In October, the journal Nanotechnology published a paper on the work called "Optical thermal response of single-walled carbon nanotube-copper sulfide nanoparticle hybrid nanomaterials." In it, researchers also say also found that they could enhance the thermal and optical switching effects of the hybrid nanomaterial as much as ten times by using asymmetric illumination, rather than symmetric illumination.

Coauthors on the Nanotechnology paper from Louisiana Tech include Yi-Hsuan Tseng, Yuan He and Que, all of the school's Institute for Micromanufacturing.

"Dr. Chen's research with nanomaterials is an important advancement with the potential for far-reaching applications," said Pamela Jansma, dean of the UT Arlington College of Science. "This is the kind of work that demonstrates the value of a research university in North Texas and beyond."

Chen is currently receiving funding from the U.S. Department of Defense to develop nanoparticle self-lighting photodynamic therapy for use against breast and prostate cancers. In 2010, he was the first to publish results in the journal Nanomedicine demonstrating that near infrared light could be used to heat copper sulfide nanoparticles for photothermal therapy in cancer treatment, which destroys cancer cells with heat between 41 and 45 degrees Celsius.

Next month, the Journal of Biomedical Nanotechnology will publish Chen's work successfully coupling gold nanoparticles with the copper sulfide nanoparticles for the photothermal therapy. Such a material would be less costly and potentially more effective than using gold particles alone, Chen said. The new paper is called "Local field enhanced Au/CuS nanocomposites as efficient photothermal transducer agents for cancer treatment."


Contact: Traci Peterson
University of Texas at Arlington

Related biology news :

1. National herpetology society honors UT Arlington professor for discoveries
2. New book on physics principles by Wayne State professor explains life as we know it
3. How a fish broke a law of physics
4. Physics and math shed new light on biology by mapping the landscape of evolution
5. Physics confirms sprinters are performing better than ever before
6. The physics of going viral
7. T cells hunt parasites like animal predators seek prey, a Penn Vet-Penn Physics study reveals
8. Young Scientist Award for Socio- and Econophysics 2012 for Arne Traulsen
9. University of Toronto study demonstrates impact of adversity on early life development
10. Published clinical trial demonstrates efficacy of Sea-Band® for migraine-related nausea
11. WALTHAM® demonstrates commitment to scientific dialogue and exchange at international human animal interaction conference
Post Your Comments:
(Date:11/18/2015)... Nov. 18, 2015  As new scientific discoveries deepen ... and other healthcare providers face challenges in better using ... patients. In addition, as more children continue to survive ... adulthood and old age. John M. Maris, ... Hospital of Philadelphia (CHOP) . --> ...
(Date:11/17/2015)... , Nov. 17, 2015 Pressure BioSciences, Inc. ... the development and sale of broadly enabling, pressure cycling ... sciences industry, today announced it has received gross proceeds ... million Private Placement (the "Offering"), increasing the total amount ... or more additional closings are expected in the near ...
(Date:11/11/2015)... MedNet Solutions , an innovative SaaS-based eClinical technology company that ... announce that it will be a Sponsor of the ... held November 17-19 in Hamburg , Germany.  ... iMedNet , MedNet,s easy-to-use, proven and affordable eClinical ... able to deliver time and cost savings of up to ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris ... that its business and prospects remain fundamentally strong ... Zoptrex™ (zoptarelin doxorubicin) recently received DSMB recommendation to ... completion following review of the final interim efficacy ... 2 Primary Endpoint in men with heavily pretreated ...
(Date:11/25/2015)... CA (PRWEB) , ... November 25, 2015 , ... ... genomics company uBiome, were featured on AngelList early in their initial angel funding ... an AngelList syndicate for individuals looking to make early stage investments in the ...
(Date:11/24/2015)... 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will ... New York on Wednesday, December 2 at 9:30 a.m. ... and CEO, will provide a corporate overview. th ... at 1:00 p.m. ET/10:00 a.m. PT . Jim Mazzola ... a corporate overview. --> th Annual Oppenheimer Healthcare ...
(Date:11/24/2015)... , Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris ... of IIROC on behalf of the Toronto Stock Exchange, ... release there are no corporate developments that would cause ... --> --> About Aeterna ... . --> Aeterna Zentaris is a ...
Breaking Biology Technology: